These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 23859491

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Is the use of esomeprazole in gastroesophageal reflux disease a cost-effective option in Poland?
    Petryszyn P, Staniak A, Grzegrzolka J.
    J Comp Eff Res; 2016 Mar; 5(2):169-78. PubMed ID: 26946951
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Gastroesophageal reflux disease in primary care: using changes in proton pump inhibitor therapy as an indicator of partial response.
    Ruigómez A, Johansson S, Wernersson B, Fernández Cantero O, García Rodríguez LA.
    Scand J Gastroenterol; 2012 Jul; 47(7):751-61. PubMed ID: 22519917
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
    Higginbotham TW.
    Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Medical and non-medical predictors of initiating long-term use of proton pump inhibitors: a nationwide cohort study of first-time users during a 10-year period.
    Haastrup PF, Paulsen MS, Christensen RD, Søndergaard J, Hansen JM, Jarbøl DE.
    Aliment Pharmacol Ther; 2016 Jul; 44(1):78-87. PubMed ID: 27137875
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical Characteristics of Patients with Gastroesophageal Reflux Disease Refractory to Proton Pump Inhibitors and the Effects of Switching to 20 mg Esomeprazole on Reflux Symptoms and Quality of Life.
    Takeshima F, Hashiguchi K, Onitsuka Y, Tanigawa K, Minami H, Matsushima K, Akazawa Y, Shiozawa K, Yamaguchi N, Taura N, Ohnita K, Ichikawa T, Isomoto H, Nakao K.
    Med Sci Monit; 2015 Dec 31; 21():4111-21. PubMed ID: 26719012
    [Abstract] [Full Text] [Related]

  • 16. Consumer use of over-the-counter proton pump inhibitors in patients with gastroesophageal reflux disease.
    Sheikh I, Waghray A, Waghray N, Dong C, Wolfe MM.
    Am J Gastroenterol; 2014 Jun 31; 109(6):789-94. PubMed ID: 24896751
    [Abstract] [Full Text] [Related]

  • 17. Factors influencing the shift of patients from one proton pump inhibitor to another: the effect of direct-to-consumer advertising.
    Hansen RA, Shaheen NJ, Schommer JC.
    Clin Ther; 2005 Sep 31; 27(9):1478-87. PubMed ID: 16291421
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A therapeutic substitution policy for proton pump inhibitors: clinical and economic consequences.
    Schneeweiss S, Maclure M, Dormuth CR, Glynn RJ, Canning C, Avorn J.
    Clin Pharmacol Ther; 2006 Apr 31; 79(4):379-88. PubMed ID: 16580906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.